Natera gains Japan approval for Signatera colorectal test
Natera (NASDAQ:NTRA) said its Signatera test has received regulatory approval from Japan’s Pharmaceuticals and Medical Devices Agency for use in colorectal cancer in the adjuvant setting.

TV presenter and finance editor at Grafa, with a Master’s in Commerce from UWA and diverse industry experience in finance, insurance, and media.
Natera (NASDAQ:NTRA) said its Signatera test has received regulatory approval from Japan’s Pharmaceuticals and Medical Devices Agency for use in colorectal cancer in the adjuvant setting.
MiniPay, the stablecoin wallet owned by Opera, has launched a Visa debit card that enables users to spend stablecoins directly from their wallets through Visa's payment network.
Meta Platforms has reportedly formed a dedicated team to develop Arena, a prediction market platform designed to compete with established operators including Polymarket and Kalshi.
Aurelia Metals (ASX:AMI) achieved financial close on its $150 million financing package to increase its available liquidity.
Baby Bunting Group (ASX:BBN) expects full-year pro forma net profit to reach $16 million to $17 million.
CBOE Global Markets is considering converting its Bitcoin (CRYPTO:BTC) and Ether (CRYPTO:ETH) futures into perpetual contracts.
Crypto prediction markets recorded more than US$2 billion in trading volume during the group stage of the 2026 FIFA World Cup.
AFT Pharmaceuticals (ASX:AFP) secured US FDA approval to launch a Phase 3 trial targeting a US$7.41 billion market.
FedEx (NYSE:FDX) reported fourth-quarter fiscal 2026 revenue of $25 billion and adjusted earnings per share of $6.60, driven by higher volumes and cost efficiency initiatives.
Oracle (NYSE:ORCL) cut about 21,000 full-time jobs over the past year while accelerating its investment in AI data center infrastructure.